302 related articles for article (PubMed ID: 32896962)
1. Major response to imatinib and chemotherapy in a newborn patient prenatally diagnosed with generalized infantile myofibromatosis.
Proust S; Benchimol G; Fraitag S; Starck J; Giacobbi V; Pierron G; Bodemer C; Orbach D
Pediatr Blood Cancer; 2021 Jan; 68(1):e28576. PubMed ID: 32896962
[No Abstract] [Full Text] [Related]
2. Treatment of generalized infantile myofibromatosis with sorafenib and imatinib: A case report.
Bidadi B; Watson A; Weigel B; Oliveira A; Kirkham J; Arndt C
Pediatr Blood Cancer; 2020 Jun; 67(6):e28288. PubMed ID: 32307894
[TBL] [Abstract][Full Text] [Related]
3. Brief report: successful therapy of a patient with infantile generalized myofibromatosis.
Day M; Edwards AO; Weinberg A; Leavey PJ
Med Pediatr Oncol; 2002 May; 38(5):371-3. PubMed ID: 11979466
[No Abstract] [Full Text] [Related]
4. Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Gandhi MM; Nathan PC; Weitzman S; Levitt GA
J Pediatr Hematol Oncol; 2003 Sep; 25(9):750-4. PubMed ID: 12972815
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for Generalized Infantile Myofibromatosis With Visceral Involvement.
Wu SY; McCavit TL; Cederberg K; Galindo RL; Leavey PJ
J Pediatr Hematol Oncol; 2015 Jul; 37(5):402-5. PubMed ID: 24608078
[TBL] [Abstract][Full Text] [Related]
6. Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene.
Mudry P; Slaby O; Neradil J; Soukalova J; Melicharkova K; Rohleder O; Jezova M; Seehofnerova A; Michu E; Veselska R; Sterba J
BMC Cancer; 2017 Feb; 17(1):119. PubMed ID: 28183292
[TBL] [Abstract][Full Text] [Related]
7. Infantile myofibromatosis.
Larralde M; Ferrari B; Martinez JP; Barbieri MAF; Méndez JH; Casas J
An Bras Dermatol; 2017; 92(6):854-857. PubMed ID: 29364448
[TBL] [Abstract][Full Text] [Related]
8. Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.
Weaver MS; Navid F; Huppmann A; Meany H; Angiolillo A
J Pediatr Hematol Oncol; 2015 Apr; 37(3):237-41. PubMed ID: 25389917
[TBL] [Abstract][Full Text] [Related]
9. PDGRFB mutation-associated myofibromatosis: Response to targeted therapy with imatinib.
Weller JM; Keil VC; Gielen GH; Herrlinger U; Schäfer N
Am J Med Genet A; 2019 Sep; 179(9):1895-1897. PubMed ID: 31291054
[TBL] [Abstract][Full Text] [Related]
10. Infantile myofibromatosis: report on a family with autosomal dominant inheritance and variable penetrance.
Kulkarni K; Desai S; Grundy P; Sergi C
J Pediatr Surg; 2012 Dec; 47(12):2312-5. PubMed ID: 23217896
[TBL] [Abstract][Full Text] [Related]
11. Generalized Infantile Myofibromatosis with Extensive Small Bowel Involvement in a Neonate.
Schubert JP; Wößmann W; Königs I; Clauditz T; Kordes U; Reinshagen K
Z Geburtshilfe Neonatol; 2023 Jun; 227(3):231-235. PubMed ID: 36921614
[TBL] [Abstract][Full Text] [Related]
12. Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
Manisterski M; Benish M; Levin D; Shiran SI; Sher O; Gortzak Y; Elhasid R
Pediatr Blood Cancer; 2021 Feb; 68(2):e28769. PubMed ID: 33063933
[TBL] [Abstract][Full Text] [Related]
13. Novel Oncogenic
Elsbernd A; Boulouadnine B; Ahmed A; Farooqi M; Sandritter T; Shakhnovich V; Blanding D; Demoulin JB; Thompson J
JCO Precis Oncol; 2022 Oct; 6():e2200250. PubMed ID: 36201717
[No Abstract] [Full Text] [Related]
14. First-line therapy of generalized infantile myofibromatosis with low-dose vinblastine and methotrexate.
Azzam R; Abboud M; Muwakkit S; Khoury N; Saab R
Pediatr Blood Cancer; 2009 Feb; 52(2):308. PubMed ID: 18937326
[No Abstract] [Full Text] [Related]
15. Massive infantile myofibromatosis of the upper lip causing airway distress in a newborn.
Wang KL; Suchomski SJ; Goldstein JD; Andreoli SM
Auris Nasus Larynx; 2020 Dec; 47(6):1049-1053. PubMed ID: 31677854
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group (ICG-AIEOP)].
Pilz T; Pilgrim TB; Bisogno G; Knietig R; Koscielniak E; Carli M; Treuner J
Klin Padiatr; 1999; 211(4):291-5. PubMed ID: 10472564
[TBL] [Abstract][Full Text] [Related]
17. Multicentric infantile myofibromatosis: two perinatal cases.
Pelluard-Nehmé F; Coatleven F; Carles D; Alberti EM; Briex M; Dallay D
Eur J Pediatr; 2007 Oct; 166(10):997-1001. PubMed ID: 17186271
[TBL] [Abstract][Full Text] [Related]
18. Infantile Myofibromatosis With Cutaneous, Visceral, and CNS Involvement: A Multimodal Approach to Therapy.
Gehle S; Quinsey C; McShane D; Thompson P; Quezada G
J Pediatr Hematol Oncol; 2023 Oct; 45(7):e921-e923. PubMed ID: 37526359
[TBL] [Abstract][Full Text] [Related]
19. [Infantile myofibromatosis of the tongue - a case-report].
Langer J; Begall K; Presch C; Erbstösser E
Laryngorhinootologie; 2002 Jun; 81(6):422-5. PubMed ID: 12063629
[TBL] [Abstract][Full Text] [Related]
20. [Infantile myofibromatosis. Study of a case using whole body ultrasound and MRI].
Machan K; Bravo Bravo C; Martínez-León MI; Affumicato L
Radiologia; 2014; 56(1):80-3. PubMed ID: 22118778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
